Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Kahnert (München, Germany), R. Jörres (München, Germany), A. Schneider (München, Germany), P. Alter (Marburg, Germany), H. Kauczor (Heidelberg, Germany), B. Jobst (Heidelberg, Germany), J. Biederer (Heidelberg, Germany), R. Bals (Homburg, Germany), H. Watz (Großhansdorf, Germany), J. Behr (Munich, Germany), D. Kauffmann-Guerrero (Munich, Germany), J. Lutter (Munich, Germany), A. Hapfelmeier (Munich, Germany), H. Magnussen (Großhansdorf, Germany), F. Trudzinski (Heidelberg, Germany), T. Welte (Hannover, Germany), C. Vogelmeier (Marburg, Germany), C. Kellerer (Marburg, Germany). Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET. 1856

Member's Comments

No comment yet.

Related content which might interest you: Prediction of air trapping or pulmonary hyperinflation by forced spirometry in COPD patients: results from COSYCONET Source: ERJ Open Res, 6 (3) 00092-2020; 10.1183/23120541.00092-2020 Year: 2020 Can emphysema predict exacerbations and changes in PFTs in COPD? Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Use of clinical characteristics to predict spirometric classification of obstructive lung disease Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Scintigraphic parameters in COPD patients Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked Year: 2013 Determinants of severity of dyspnea in COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 The clinical significance and frequency of bronchiectasis in COPD patients Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Do all COPD patients present irreversible airflow limitation? Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013 Relationship between clinical and radiological signs of bronchiectasis in COPD patients: Results from COSYCONET Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Lung function change and exacerbations in patients with COPD in the WISDOM study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study Source: Eur Respir J 2009; 34: 588 Year: 2009 Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction? Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Telespirometry performed by general practitioners for early diagnosis of obstructive airway disease: Our experience Source: International Congress 2014 – Respiratory function: quality and new technologies Year: 2014 An evaluation of the validity of two measurements of dyspnoea as outcomes of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 182s Year: 2002 Bronchodilator response of advanced lung function parameters depending on COPD severity Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Severity of airflow obstruction and multicomponent disease staging of COPD in the real-world primary care in Greece: The AEOLUS study Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016